EGPAF

Accelerating Access to Optimal Child-Friendly Antiretroviral Formulations for Children Living with HIV: Lessons Learned from Eight Sub-Saharan African Countries

rlekirkegaard — Fri, 28 May 2021 17:48:37 +0000

Accelerating Access to Optimal Child-Friendly Antiretroviral Formulations for Children Living with HIV: Lessons Learned from Eight Sub-Saharan African Countries rlekirkegaard Fri, 05/28/2021 - 20:48

EGPAF, with funding and support from Unitaid and DNDi, is bringing new-to-market pediatric ARV formulations to full-scale implementation in eight African countries. We gathered and documented lessons learned from these eight project countries to inform, streamline and accelerate the introduction and roll-out of new, child-friendly ARVs so that all children living with HIV have access to optimal, WHO-recommended treatment and care.

Paediatric and Adolescent Treatment

Organization Tag

Region Tags

Population Tags

Topic Tags

Paediatric ARVs and formulations

Document Type Tags

Case study

Year Tags

2021

Download file(s)

Paediatric ARV-Lessons-Learned-Brief

COVID-19 and Pregnancy: Research to Date

admin — Mon, 20 Apr 2020 20:01:08 +0000

COVID-19 and Pregnancy: Research to Date

Elizabeth Glaser Pediatric AIDS Foundation

Back to COVID-19 page

admin Mon, 04/20/2020 - 23:01

EGPAF

Partner

Year Tags

2020

Site Monitoring Guidance and Checklists

admin — Tue, 30 Jul 2019 18:51:08 +0000

Site Monitoring Guidance and Checklists admin Tue, 07/30/2019 - 21:51

Regular monitoring of POC EID implementation sites is crucial for ensuring the quality and efficacy of site-level operations throughout the project. Site monitoring visits will provide essential insights into site-level issues related to human resources, patient flow, platform functioning, end user performance, specimen transport, data, data quality, and capacity building needs of site level staff.

Author: EGPAF

Year: 2017

Organization Tag

Population Tags

Year Tags

Download file(s)

Site Monitoring Guidance

Hub Testing Site - POC-EID.pdf

Spoke Site - POC-EID.pdf

Stand Alone Testing Site - POC-EID.pdf

Post-Market Surveillance

admin — Tue, 30 Jul 2019 18:48:35 +0000

Post-Market Surveillance admin Tue, 07/30/2019 - 21:48

Post-market surveillance aims to ensure that IVDs continue to meet the same quality, safety and performance requirements as when they were initially placed on the market. WHO has developed normative guidance on post-market surveillance of in vitro diagnostics, emphasizing the importance of both reactive post-market surveillance and proactive post-market surveillance activities.

Reactive post-market surveillance refers to activities undertaken after an issue has occurred related to the IVD test (e.g., complaint reporting/monitoring; end user quality control programs, etc.), whereas proactive post-market surveillance refers to scans for potential issues related to the IVD (e.g., pre- and/or post-distribution lot testing). Lot testing involves testing samples from a manufacturing lot to ensure performance meets an acceptable standard.

For additional information on post-market surveillance, including sample reporting forms, see http://www.who.int/diagnostics_laboratory/postmarket/en/

Organization Tag

Population Tags

Document Type Tags

Year Tags

Post-market surveillance

Competency Assessment Guide and Forms

admin — Tue, 30 Jul 2019 18:44:59 +0000

Competency Assessment Guide and Forms admin Tue, 07/30/2019 - 21:44

Regular assessments of the competency of POC EID device operators are crucial for ensuring the quality of the testing procedure at an individual level, and can also serve as a key component of a POC EID quality assurance (QA) scheme.

Author: EGPAF

Year: 2019

Organization Tag

Population Tags

Topic Tags

Document Type Tags